Awm Investment Company, Inc. Neuronetics, Inc. Transaction History
Awm Investment Company, Inc.
- $697 Million
- Q2 2025
A detailed history of Awm Investment Company, Inc. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Awm Investment Company, Inc. holds 245,924 shares of STIM stock, worth $700,883. This represents 0.12% of its overall portfolio holdings.
Number of Shares
245,924
Previous 245,924
-0.0%
Holding current value
$700,883
Previous $905,000
5.19%
% of portfolio
0.12%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding STIM
# of Institutions
94Shares Held
18.5MCall Options Held
49.6KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA2.74MShares$7.82 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$4.95 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.51MShares$4.3 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$3.13 Million1.17% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$2.85 Million0.14% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $77M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...